Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 13/20 | 0.62 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.62 |
| ▸ | NQO2 | P16083 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30589884 | 1.00 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2SMN1; SMN2SIGMAR1 | |
| SCHEMBL7787100 | 0.93 | MTNR1A (0.54) | MTNR1AMTNR1BNQO2SIGMAR1ABCB1 | |
| SCHEMBL7786940 | 0.92 | MTNR1A (0.53) | MTNR1AMTNR1BNQO2SIGMAR1ABCB1 | |
| SCHEMBL17634070 | 0.89 | MTNR1A (0.49) | MTNR1AMTNR1BNQO2SMN1; SMN2HTR2C | |
| SCHEMBL17643487 | 0.89 | MTNR1A (0.49) | MTNR1AMTNR1BNQO2SMN1; SMN2SIGMAR1 | |
| SCHEMBL7784332 | 0.89 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2SMN1; SMN2HTR2C | |
| SCHEMBL17634073 | 0.86 | MTNR1A (0.47) | MTNR1AMTNR1BNQO2SMN1; SMN2SIGMAR1 | |
| SCHEMBL17634080 | 0.86 | MTNR1A (0.52) | MTNR1AMTNR1BNQO2SMN1; SMN2 | |
| SCHEMBL17634076 | 0.85 | MTNR1A (0.48) | MTNR1AMTNR1BNQO2SMN1; SMN2 | |
| SCHEMBL17634082 | 0.84 | MTNR1A (0.46) | MTNR1AMTNR1BNQO2SMN1; SMN2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2705023-A1 | PROCESSES FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)ETHYL]ACETAMIDE | Symed Labs Limited (IN) | 2014-03-12 | — | — | EP | claimed |
| WO-2012093402-A1 | PROCESSES FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)ETHYL]ACETAMIDE | SYMED LABS LIMITED (IN) | 2012-07-12 | — | — | WO | claimed |
| WO-2012046253-A2 | PROCESS FOR THE PREPARATION OF N-[2- (7-METHOXY-L-NAPHTHYL) ETHYL] ACETAMIDE AND ITS NOVEL CRYSTALLINE FORMS | MSN LABORATORIES LIMITED (IN) | 2012-04-12 | — | — | WO | claimed |
| EP-2580189-B1 | AGOMELATINE INTERMEDIATES AND PREPARATION METHOD THEREOF | SERVIER LAB (FR) | 2017-10-25 | — | — | EP | disclosed |
| EP-2580189-B1 | AGOMELATINE INTERMEDIATES AND PREPARATION METHOD THEREOF | SERVIER LAB (FR) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016046833-A2 | IMPROVED PROCESSES FOR THE PREPARATION OF AGOMELATINE USING NOVEL INTERMEDIATES | SYMED LABS LIMITED (IN) | 2016-03-31 | — | — | WO | disclosed |
| EP-2909166-A1 | PROCESSES FOR THE PREPARATION OF AGOMELATINE USING NOVEL INTERMEDIATES | Symed Labs Limited (IN) | 2015-08-26 | — | — | EP | disclosed |
| WO-2015000555-A2 | A NOVEL PROCESS FOR THE PREPARATION OF TETRALIN AND NAPHTHALENE DERIVATIVES | PHARMATHEN S.A. (GR) | 2015-01-08 | — | — | WO | disclosed |
| EP-2580183-B1 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE | GADOR SA (AR) | 2014-07-23 | — | — | EP | disclosed |
| EP-2580183-B1 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE | GADOR SA (AR) | 2014-07-23 | — | — | EP | disclosed |
| US-8779199-B2 | Agomelatine intermediates and preparation method thereof | LES LABORATOIRES SERVIER (FR) | 2014-07-15 | — | — | US | disclosed |
| WO-2012046253-A2 | PROCESS FOR THE PREPARATION OF N-[2- (7-METHOXY-L-NAPHTHYL) ETHYL] ACETAMIDE AND ITS NOVEL CRYSTALLINE FORMS | MSN LABORATORIES LIMITED (IN) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012046253-A2 | PROCESS FOR THE PREPARATION OF N-[2- (7-METHOXY-L-NAPHTHYL) ETHYL] ACETAMIDE AND ITS NOVEL CRYSTALLINE FORMS | MSN LABORATORIES LIMITED (IN) | 2012-04-12 | — | — | WO | disclosed |
| WO-2011153939-A1 | AGOMELATINE INTERMEDIATES AND PREPARATION METHOD THEREOF | LES LABORATOIRES SERVIER (FR) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011154140-A2 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE AND NEW CRYSTALLINE FORM | GADOR S.A. (AR) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011154140-A2 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE AND NEW CRYSTALLINE FORM | GADOR S.A. (AR) | 2011-12-15 | — | — | WO | disclosed |
| EP-0848699-B1 | BENZOCYCLOALKENE COMPOUNDS WITH MELATONINE RECEPTOR BINDING AFFINITY, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-10-24 | — | — | EP | disclosed |
| US-5922771-A | MELATONIN RECEPTOR AGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-07-13 | — | — | US | disclosed |
| EP-0848699-A1 | BENZOCYCLOALKENE COMPOUNDS WITH MELATONINE RECEPTOR BINDING AFFINITY, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1998-06-24 | — | — | EP | disclosed |
| WO-1997005098-A1 | BENZOCYCLOALKENE COMPOUNDS WITH MELATONINE RECEPTOR BINDING AFFINITY, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-02-13 | — | — | WO | disclosed |